Latest News
Industrial Opportunity Partners (IOP), an operations-focused private equity firm, has completed the sale of portfolio company Midwest Paper Group Holdings, Inc (Midwest Paper) to McKinley Paper Company, a subsidiary of Bio Pappel SA de CV (Bio Pappel), a manufacturer of paper and packaging products in North and Latin America.
IOP acquired Midwest Paper in December 2019.
The divestiture represents IOP’s first investment realisation from its USD450 million third fund, Industrial Opportunity Partners III.
Terms of the transaction have not been disclosed.
Private investment firm Inverness Graham’s Governance, Risk and Compliance (GRC) solutions company, Syntrio, has acquired ClearView Strategic Partners (ClearView), a provider of ethics reporting & management systems and whistleblower technology solutions.
The transaction marks the fifth add-on acquisition completed during Inverness Graham’s ownership, and will provide Syntrio with access to key international geographies as well as an expanded software solutions offering.
Global law firm Hogan Lovells has added to its Corporate & Finance practice group with the arrival of private equity partner Parikshit Dasgupta in New York.
Dasgupta is the third partner to join the Corporate & Finance practice group in the United States in 2022.
Dasgupta joins the firm from Reed Smith, where he was a partner. His practice focuses on the establishment, management, and regulation of private investment funds. He regularly represents both US and non-US sponsors of buyout, growth capital, secondary, distressed debt, energy, infrastructure, technology, venture, credit opportunities, and geographically oriented funds. Dasgupta advises on spin-outs,
Glennmont Partners from Nuveen (Glennmont) has invested in a EUR100 million Bonds programme dedicated to financing energy efficiency improvements on residential buildings in Italy.
Gen II Fund Services, an independent private equity fund administrator, has promoted six of its client service professionals to Principal, bringing the number of Gen II Principals to thirty-three (33).
The newly-appointed Principals are: Joshua Feldstein, Jonathan Goldstein; Michael Hall; James Myers, Yeva Rakhamimova, and Richard Zheng.
GAM Investments has entered into a strategic partnership with Liberty Street Advisors (Liberty Street) to provide clients with access to leading late-stage privately-owned technology and innovation-driven companies.
In partnership with Liberty Street, GAM plans to launch a capability which will leverage the expertise of Liberty Street’s private markets investment team. This capability will give clients the opportunity to gain exposure to a market which has historically been difficult for them to access.
St Andrews-based investment firm Eos Advisory’s portfolio has reached a total valuation of GBP121 million based on latest investment rounds, and its first two exit events in 2021, including when Genus Plc acquired a large stake in aquaculture specialist Xelect.
In January 2021, Eos announced that it had led a GB{1.24 million investment into RAB-Microfluidics, an Aberdeen-headquartered R&D company developing cutting-edge microfluidic technology to diagnose engine and turbine wear in real time. Founded by CEO Rotimi Alabi, RAB-Microfluidics has since grown the team and gained significant sales.
In February 2021, Eos secured its first strategic investment partnership with US-based Kineticos
Vensica Therapeutics (Vensica), a clinical stage biopharmaceutical company, has closed a USD19 million investment round.
Vensica executed a strategic collaboration agreement with Merz Therapeutics in 2021 and the Merz Group is participating in Vensica’s financing with up to USD3 million, bringing the total round to up to USD19 million. The round was led by Israel Biotech Fund (IBF) with the participation of Laborie, Lew Pell, Agriline, and The Trendlines Group.
Merz Therapeutics, a business of the Merz Group, is a specialist in the field of neurotoxins. Vensica has exclusively licensed Merz’s botulinum neurotoxin A (Xeomin®) for needle-free use in urological
Reliance Health, an emerging markets-focused digital healthcare provider, has secured USD40 million in a Series B funding round led by General Atlantic.
Partech, Picus Capital, Tencent Exploration, AAIC (Asia Africa Investment and Consulting), P1 Ventures, Laerdal Million Lives Fund, M3, Inc, and Arvantis Social Foundation also participated.
With this funding, Reliance Health has successfully closed the largest Series B round in the African HealthTech industry to date. The newly-established partnership also marks General Atlantic’s first technology investment in Africa. To date, Reliance Health has raised USD48 million in total funding, including a USD6 million Series A funding round in January
O2 Investment Partners has appointed Andrew Faubel as the firm’s newest Jr Vice President.
Prior to joining O2, Faubel was with Crescent Cove, a TMT focused multi-strategy investment firm based in San Francisco.
Prior to that, he was with Evercore in New York and San Francisco, advising corporate clients on M&A and capital markets transactions, having begun his career at Bank of America in New York, advising institutional and ultra high net worth clients on investment strategy.
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
